ZA861476B - 15(r)-5-fluroprostacyclins,pharmaceutical composition and antithrombotic methods and use thereof - Google Patents

15(r)-5-fluroprostacyclins,pharmaceutical composition and antithrombotic methods and use thereof

Info

Publication number
ZA861476B
ZA861476B ZA861476A ZA861476A ZA861476B ZA 861476 B ZA861476 B ZA 861476B ZA 861476 A ZA861476 A ZA 861476A ZA 861476 A ZA861476 A ZA 861476A ZA 861476 B ZA861476 B ZA 861476B
Authority
ZA
South Africa
Prior art keywords
fluroprostacyclins
pharmaceutical composition
antithrombotic
methods
antithrombotic methods
Prior art date
Application number
ZA861476A
Other languages
English (en)
Inventor
Stevan Wakefield Djuric
Robert Bruce Garland
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ZA861476B publication Critical patent/ZA861476B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
ZA861476A 1985-02-28 1986-02-27 15(r)-5-fluroprostacyclins,pharmaceutical composition and antithrombotic methods and use thereof ZA861476B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/706,806 US4616034A (en) 1985-02-28 1985-02-28 15(R)-5-fluoroprostacyclins, pharmaceutical compositions and anti-thrombotic method of use thereof

Publications (1)

Publication Number Publication Date
ZA861476B true ZA861476B (en) 1987-05-27

Family

ID=24839120

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA861476A ZA861476B (en) 1985-02-28 1986-02-27 15(r)-5-fluroprostacyclins,pharmaceutical composition and antithrombotic methods and use thereof

Country Status (6)

Country Link
US (1) US4616034A (xx)
EP (1) EP0193194B1 (xx)
JP (1) JPS61205271A (xx)
AU (1) AU5412886A (xx)
DE (1) DE3676097D1 (xx)
ZA (1) ZA861476B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719220A (en) * 1985-02-28 1988-01-12 G. D. Searle & Co. 15(R)-5-fluoroprostacyclins, pharmaceutical compositions and anti-thrombotic methods of use thereof
US4808734A (en) * 1986-12-01 1989-02-28 Hoffmann-La Roche Inc. 16-cycloalkyl-7-fluoro-prostacyclins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
IT1088036B (it) * 1977-11-25 1985-06-04 Erba Carlo Spa 15-epi-prostaciclina e prostaciclina analoghi
US4324730A (en) * 1979-10-10 1982-04-13 The University Of Chicago Certain fluorine substituted PGI2 compounds
WO1981001002A1 (en) * 1979-10-10 1981-04-16 Univ Chicago Fluoro-substituted prostaglandins and prostacyclins
EP0054795B1 (en) * 1980-12-09 1987-07-15 Teijin Limited Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof
US4540801A (en) * 1981-04-02 1985-09-10 G. D. Searle & Co. 5 Fluoro PGI compounds
IE52937B1 (en) * 1981-04-02 1988-04-13 Searle & Co 5 fluoro pgi compounds
JPS58150583A (ja) * 1982-03-04 1983-09-07 Teijin Ltd 新規なハロゲン化プロスタサイクリン類、それらの製造法およびそれらを活性成分とする薬学的組成物

Also Published As

Publication number Publication date
AU5412886A (en) 1986-09-04
EP0193194B1 (en) 1990-12-12
US4616034A (en) 1986-10-07
DE3676097D1 (de) 1991-01-24
EP0193194A2 (en) 1986-09-03
EP0193194A3 (en) 1987-09-02
JPS61205271A (ja) 1986-09-11

Similar Documents

Publication Publication Date Title
PH25126A (en) 1,5-diaryl-3-substituted pyrazoles pharmaceutical compositions and use
NZ218089A (en) 7-piperazinyl, 4-oxoquinolines and pharmaceutical compositions
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
IL84832A (en) 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5- tetrahydropyridazin-3- ones, their preparation and pharmaceutical compositions containing them
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
IL76823A0 (en) 1,2,4-triazolo-carbamates,their preparation and pharmaceutical compositions containing them
ZA868752B (en) 6,7,8,9-tetrahydro-10-methylpyrido(1,2-a)indol-9-amines and derivatives thereof
AU6292286A (en) N-substituted-3,4,5,6,-tetrahydrophthalimides, their preparation and use
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
GB2182929B (en) Difluorinated (5,6,11,12-tetraselenotetracene)2 halides, the preparation thereof and the use thereof
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
NZ218087A (en) 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and pharmaceutical compositions
IL78538A0 (en) (-)-1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,7,12,12b alpha-octahydroindolo(2,3-a)-quinolizine,its preparation and pharmaceutical compositions containing them
NZ216325A (en) #w# 4,9 -11b-substituted steroids and pharmaceutical compositions
NZ216555A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
NZ217248A (en) Gem-dihalo-1,8-diamino-4-aza-octones and pharmaceutical compositions
NZ219719A (en) Endo-4-amino-5-chloro-2-methoxy-n-cl-azabicyclo -(3,3,1)-non-4-yl)-benzamide and pharmaceutical compositions
IL80733A0 (en) 2,2'-bi-1h-imidazoles and pharmaceutical compositions containing same
NZ215083A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
ZA861476B (en) 15(r)-5-fluroprostacyclins,pharmaceutical composition and antithrombotic methods and use thereof
ZA86659B (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it